These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34969061)

  • 1. Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges.
    Terrier O; Si-Tahar M; Ducatez M; Chevalier C; Pizzorno A; Le Goffic R; Crépin T; Simon G; Naffakh N
    PLoS Pathog; 2021 Dec; 17(12):e1010106. PubMed ID: 34969061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.
    Flerlage T; Boyd DF; Meliopoulos V; Thomas PG; Schultz-Cherry S
    Nat Rev Microbiol; 2021 Jul; 19(7):425-441. PubMed ID: 33824495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2.
    Amoutzias GD; Nikolaidis M; Tryfonopoulou E; Chlichlia K; Markoulatos P; Oliver SG
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus evolution, host adaptation, and pandemic formation.
    Taubenberger JK; Kash JC
    Cell Host Microbe; 2010 Jun; 7(6):440-51. PubMed ID: 20542248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States.
    Feng L; Zhang T; Wang Q; Xie Y; Peng Z; Zheng J; Qin Y; Zhang M; Lai S; Wang D; Feng Z; Li Z; Gao GF
    Nat Commun; 2021 May; 12(1):3249. PubMed ID: 34059675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decavalent composite mRNA vaccine against both influenza and COVID-19.
    Wang Y; Ma Q; Li M; Mai Q; Ma L; Zhang H; Zhong H; Mai K; Cheng N; Feng P; Guan P; Wu S; Zhang L; Dai J; Zhang B; Pan W; Yang Z
    mBio; 2024 Sep; 15(9):e0066824. PubMed ID: 39105586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic.
    To KK; Sridhar S; Chiu KH; Hung DL; Li X; Hung IF; Tam AR; Chung TW; Chan JF; Zhang AJ; Cheng VC; Yuen KY
    Emerg Microbes Infect; 2021 Dec; 10(1):507-535. PubMed ID: 33666147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
    Fung TS; Liu DX
    Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disappearance of respiratory syncytial virus and influenza viruses in children during the second year of the COVID-19 pandemic - are non-pharmaceutical interventions as effective as vaccines?
    Kışlal FM; Hanilçe Y; Altaş B; Büyükbaşaran ZE; Güven D
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3777-3783. PubMed ID: 37140326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
    Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
    Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).
    Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Mohaini MA; Aldali J; Tirupathi R; Sule AA; Koritala T; Adhikari R; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Sami SA; Mitra S; Pandey MK; Harapan H; Emran TB; Dhama K
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7162-7184. PubMed ID: 34859882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge.
    Wang G; Verma AK; Guan X; Bu F; Odle AE; Li F; Liu B; Perlman S; Du L
    J Virol; 2024 Sep; 98(9):e0037624. PubMed ID: 39189731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.
    Bolinger AA; Li J; Xie X; Li H; Zhou J
    Expert Opin Drug Discov; 2024 Sep; 19(9):1023-1041. PubMed ID: 39078037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
    Huang W; Guo Y; Li N; Feng Y; Xiao L
    Infect Genet Evol; 2021 Apr; 89():104736. PubMed ID: 33516969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
    Abdelrahman Z; Li M; Wang X
    Front Immunol; 2020; 11():552909. PubMed ID: 33013925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.